Total protein was extracted from cells and tissue with the addition of 20 mM N‐ethylmaleimide (Sigma‐Aldrich), and protein was quantified with a BCA kit. Protein samples were separated on 9% SDS‐PAGE gels and transferred to nitrocellulose‐filter membranes. Then, membranes were probed with the following primary antibodies against RNF4 (1:500; Creative Diagnostics, USA), GAPDH (1:10000; ABclonal, USA), actin (1:1000; Proteintech, USA), ubiquitin (1:600; Santa Cruz Biotechnology, USA), PML (1:1000; MBL, Japan), SUMO‐1 (1:200; Santa Cruz Biotechnology, USA), SUMO‐2/3 (1:500; Abcam, USA), p53 (1:800; Abcam, USA) and p‐p53 (1:1000; Cell Signaling Technology, USA). Immunoblots were observed by a LI‐COR Imaging System (LI‐COR Biosciences, Lincoln, NE), and Odyssey software was used to analyse band intensities (area × OD), which were normalized to GAPDH/Actin. Results are reported as fold changes normalized to control values.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.